Head and Neck Squamous Cell Carcinoma (HNSCC) Not Yet Recruiting Phase 1 Trials for DB11760 (Talazoparib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02567396Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionTreatment